MarketsandMarkets

Radiotherapy Market Worth $5.8 Billion by 2016

The global market, consisting of devices used in both systemic and blood-borne oncology treatment procedures, was valued at $4.4 billion in 2011 and is expected to reach $5.8 billion by 2016, at a CAGR of 5.3% from 2011 to 2016.

Dallas, TX -- (SBWIRE) -- 03/25/2014 -- The “Radiotherapy Market By Technology, Applications & Products (2011 – 2016)”, published by MarketsandMarkets analyzes and studies the major market drivers, restraints, and opportunities in Americas, Europe, Asia, and Rest of the World including Japan.

This report studies the global radiotherapy devices market over the forecast period 2011-2016.
The global radiotherapy devices market is classified into external radiotherapy, internal radiotherapy (brachytherapy) and systemic radiotherapy. The radiation therapy market is expected to grow at a faster rate with a CAGR of 5.3% from 2011 to 2016.

Radiation therapy is one of the advanced treatment and diagnostic procedures to kill damaged cells using focused energy with an intension to limiting harmful effects to the neighbouring healthy cells. Radiotherapy is generally applied either alone or along with the combination of surgery or chemotherapy. The major driving force in the advancements in radiation oncology over the conventional radiotherapy is the unique therapeutic effect on genetic materials of damaged cells. Radiotherapy interrupts cell replication and causes the cell-death eventually.

The global radiotherapy market has seen challenging and dynamic market conditions, but still remains strong, with a size of approximately $4.4 billion in 2011, at an estimated annual growth rate of 5.3% over the next five years. A large number of technological innovations in the devices used in such procedures have been seen in the past years, with newer devices coming up with better safety and efficacy attributes contributing to widespread adoption of the radiotherapy procedures by physicians worldwide.

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.